Patents by Inventor Matthew Pompili

Matthew Pompili has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid forms of nilotinib hydrochloride
    Patent number: 10016423
    Abstract: A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: July 10, 2018
    Assignee: Apotex Inc.
    Inventors: Matthew Pompili, David A. Stradiotto, Probal Kanti Datta
  • Solid Forms of Nilotinib Hydrochloride
    Publication number: 20170239247
    Abstract: A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
    Type: Application
    Filed: October 15, 2015
    Publication date: August 24, 2017
    Applicant: Apotex Inc.
    Inventors: Matthew Pompili, David A. Stradiotto, Probal Kanti Datta